He claims they got "rejected" by the FDA so uk will do the same... False the FDA asked or additional data which has now been availible for some time which the uk can easily access. And the additional data was positive.
What a poorly written article. It was the cause for ALIM falling out today. This guy needs to write more clearly instead of mumbo, jumboing, around. Ridiculous. He indicates; If it gets approved in US or by EU it will cause serious upside in share price. If it is approved ALIM will try to buy drug from PSDV (really?). The FDA allowed the additional data only to give another CRL (poor argument), if they don't like the 3 year efficacy, it still could possibly be approved for 2 year dosing. It is safe enough. Look at the problems with off-label use of Avastin causing infections and blindness in the news today. One less competitor and lawsuits for practitioners using Avastin which is more frequently injected. This drug is even more needed at this time.
Kitty tired of poor written BS article. The guy may need shoot of bamboo treatment from Siam.